Sesen Bio, Inc.

SESN NASDAQ
1.220
+0.050
+4.27%
盘后: 1.220 0 0.00% 17:38 08/21 EDT
开盘
1.200
昨收
1.170
最高
1.230
最低
1.170
成交量
123.37万
成交均量(3M)
257.07万
52周最高
2.600
52周最低
0.6609
换手率
1.22%
市值
1.24亿
分时
5日
1月
3月
1年
5年

相关股票

微牛行情栏目提供Sesen Bio, Inc. SESN股票价格,Sesen Bio, Inc.股票实时行情,公司简介,财报信息,股本结构等,掌握美港股行情走势,开盘价,收盘价,总市值,换手率,市盈率,收益率等数据,及时把握美股港股投资机会。

公司介绍

Sesen Bio, Inc., formerly Eleven Biotherapeutics, Inc., is a late-stage clinical company that provides targeted protein therapeutics (TPT) platform. The Company is focused on developing antibody-drug conjugate (ADC) therapies for the treatment of cancer. Its product pipeline includes Vicinium, Vicinium in combination with checkpoint inhibator, durvalumab, and VB6-845d. The Company’s lead program, Vicinium, is a fusion protein in Phase III development for the treatment of non-muscle invasive bladder cancer (NMIBC). It targets epithelial cell adhesion molecule (EpCAM) antigens on the surface of tumor cells to deliver a potent cytotoxin, Pseudomonas Exotoxin A (ETA) directly to cancer cells.
展开 >

最近浏览

名称
价格
涨跌幅